TY - JOUR A1 - Oehme, Stephan A1 - Moewis, Philippe A1 - Boeth, Heide A1 - Bartek, Benjamin A1 - von Tycowicz, Christoph A1 - Ehrig, Rainald A1 - Duda, Georg A1 - Jung, Tobias T1 - Altered knee kinematics after posterior cruciate single-bundle reconstruction - a comprehensive prospective biomechanical in vivo analysis JF - Frontiers in Bioengineering and Biotechnology Y1 - 2024 U6 - https://doi.org/10.3389/fbioe.2024.1322136 VL - 12 ER - TY - JOUR A1 - Oehme, Stephan A1 - Moewis, Philippe A1 - Boeth, Heide A1 - Bartek, Benjamin A1 - Lippert, Annika A1 - von Tycowicz, Christoph A1 - Ehrig, Rainald A1 - Duda, Georg A1 - Jung, Tobias T1 - PCL insufficient patients with increased translational and rotational passive knee joint laxity have no increased range of anterior–posterior and rotational tibiofemoral motion during level walking JF - Scientific Reports Y1 - 2022 U6 - https://doi.org/10.1038/s41598-022-17328-3 VL - 12 IS - 1 SP - 1 EP - 11 ER - TY - JOUR A1 - Boeth, Heide A1 - Biesen, Robert A1 - Hollnagel, Jeremias A1 - Herrmann, Sandra A1 - Ehrig, Rainald A1 - Pelli, Lorenzo A1 - Taylor, William R. A1 - Duda, Georg A1 - Buttgereit, Frank T1 - Quantification of morning stiffness to assess disease activity and treatment effects in rheumatoid arthritis JF - Rheumatology N2 - Objectives The clinical parameter “morning stiffness” is widely used to assess the status of rheumatoid arthritis (RA), but its accurate quantitative assessment in a clinical setting has not yet been successful. This lack of individual quantification limits both personalized medication and efficacy evaluation in the treatment of RA. Methods We have developed a novel technology to assess passive resistance of the metacarpophalangeal (MCP) III joint (stiffness) and its Passive Range of Motion (PRoM). Within this pilot study, nineteen female postmenopausal RA patients and nine healthy controls were examined in the evening as well as in the morning of the following day. To verify the specificity of the biomechanical quantification, eleven patients with RA were assessed both prior to and ∼3 h after glucocorticoid therapy. Results While the healthy controls showed only minor changes between afternoon and morning, in RA patients mean±SD PRoM decreased significantly by 18 ± 22% and stiffness increased significantly by 20 ± 18% in the morning compared with the previous afternoon. We found a significant positive correlation between RA activity and biomechanical measures. Glucocorticoids significantly increased mean PRoM by 16 ± 11% and reduced mean stiffness by 23 ± 22%. Conclusion This technology allowed mechanical stiffness to be quantified in MCP joints, and has demonstrated high sensitivity in respect to disease status as well as medication effect in RA patients. Such non-invasive, low risk, and rapid assessment of biomechanical joint stiffness opens a novel avenue for judging therapy efficacy in patients with RA, and potentially also in other non-RA inflammatory joint diseases. Y1 - 2021 U6 - https://doi.org/10.1093/rheumatology/keab323 VL - 60 IS - 11 SP - 5282 EP - 5291 ER -